Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008741

Chief Financial Officer bought 1,200 shares at $20.00 ($24,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quinn William P. Chief Financial Officer 2021-02-09 Purchase +1,200 $20.00 $24,000 13,898 D
Open-market purchases · 1,200 sh · avg $20.00 · $24,000
Loading xslF345X03/doc4.xml…